RxDoctor Payments Data

Carla Branch, MD

Family Medicine · Statesboro, GANPI 1851394969

Payments from drug & device makers

$9,274in general payments, 2019–2025

Across 587 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$978
  • Novo Nordisk$942
  • AstraZeneca$727
  • Pfizer$580
  • Amgen$543
  • Boehringer Ingelheim$537
  • plus $5K from 44 others

What the payments were for

  • Food & beverage$9,274100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,274 in reported general payments places this provider in the 90th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$80,743
Medicare patients
348
Services billed
953

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide89$141,632
JardianceEmpagliflozin110$109,539
FarxigaDapagliflozin Propanediol107$102,242
OzempicSemaglutide60$97,893
MounjaroTirzepatide69$87,792
EliquisApixaban89$80,459
JanuviaSitagliptin Phosphate70$75,795
TrulicityDulaglutide40$52,113
Trelegy ElliptaFluticasone/Umeclidin/Vilanter51$51,502
LinzessLinaclotide25$36,884
Tresiba Flextouch U-100Insulin Degludec48$29,298
RexultiBrexpiprazole13$18,779
Janumet XrSitagliptin Phos/Metformin Hcl14$18,017
Tresiba Flextouch U-200Insulin Degludec31$17,287
ShingrixVaricella-Zoster Ge/As01b/Pf76$16,888

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$942$239,525149 claims
Lilly USA, LLCMounjaro, Trulicity$537$139,905109 claims
Boehringer IngelheimJardiance$537$109,539110 claims
AstraZenecaFarxiga, Symbicort$727$108,675133 claims
MerckJanuvia, Janumet Xr, Belsomra$170$101,17295 claims
PfizerEliquis$580$80,45989 claims
GSKTrelegy Ellipta, Shingrix, Anoro Ellipta, Breo Ellipta$334$79,785153 claims
AbbVieLinzess, Synthroid$978$39,92270 claims
Otsuka America Pharmaceutical, Inc.Rexulti$205$18,77913 claims
Johnson & JohnsonXarelto$55$13,71417 claims
Astellas Pharma US IncMyrbetriq$44$11,39620 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Statesboro

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →